Within the breast cancer tissue, BCSCs with CD44+/CD24−/low phenotype are closely present to the invasive edge, whereas BCSCs with elevated ALDH1 activity are primarily found in the inner regions where hypoxia is predominant [71,72]. Here, CD44 is linked to breast carcinoma.